| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/04/2002 | EP0702723B1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 09/04/2002 | EP0682526B1 PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1 |
| 09/04/2002 | EP0636696B1 Process for producing recombinant major histocompatibility antigen class ii protein in microorganisms |
| 09/04/2002 | EP0605680B1 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 09/04/2002 | EP0590006B1 Synthetic pulmonary surfactant peptides |
| 09/04/2002 | EP0205475B2 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
| 09/04/2002 | CN1367875A Induction method of TH1-like response in vitro |
| 09/04/2002 | CN1367839A Paramyxoviruses having modified transcription initiation sequence |
| 09/04/2002 | CN1367838A Promoters for expressing genes in fungal cell |
| 09/04/2002 | CN1367837A Production of proteins by autoproteolytic cleavage |
| 09/04/2002 | CN1367836A CHP polypeptide as ligand of PAK65 |
| 09/04/2002 | CN1367834A Proteins derived from white spot syndrome virus and uses thereof |
| 09/04/2002 | CN1367833A Streptococcus pneumoniae proteins and nucleic acid molecules |
| 09/04/2002 | CN1367832A Ehrlichia canis genes and vaccines |
| 09/04/2002 | CN1367831A Use of BNM3 transcriptional activator to control plant embryogenesis and regeneration process |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |
| 09/04/2002 | CN1367829A Compositions and methods for therapy and diagnosis of lung cancer |
| 09/04/2002 | CN1367794A Stabilized denatured lipoprotein and process for producing the same |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367791A Novel angiogenesis inhibitor |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367789A Synthesis of template-fixed beta-hairpin loop mimetics |
| 09/04/2002 | CN1367686A Novel compositions |
| 09/04/2002 | CN1367676A Preserving hemoglobin blood substitute with transparent overwrap |
| 09/04/2002 | CN1367248A Novel tumor wilting matter 2 ligand gene, its expressed tumor wilting matter and its preparation method |
| 09/04/2002 | CN1367180A Novel natural antibacterial peptide, its code sequence and application |
| 09/04/2002 | CN1367179A Novel liver regeneration related protein, its code sequence and application |
| 09/04/2002 | CN1367178A Technological process for extracting and purifying deer's fetus extract |
| 09/04/2002 | CN1367177A Antibactrial polypeptide separated from biological living body |
| 09/04/2002 | CN1367176A Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method |
| 09/04/2002 | CN1090239C Recombinant virus vectors |
| 09/04/2002 | CN1090238C Process for producing enzyme |
| 09/04/2002 | CA2445692A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/04/2002 | CA2444812A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/04/2002 | CA2444802A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/03/2002 | US6444877 Liquidambar styraciflua AGAMOUS (LSAG) gene |
| 09/03/2002 | US6444873 MSH5 ablated mice and uses therefor |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444803 Bone mineralization proteins, DNA, vectors, expression systems |
| 09/03/2002 | US6444801 Transcriptional inhibitor protein and the encoding DNA |
| 09/03/2002 | US6444800 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 09/03/2002 | US6444799 P. gingivalis polynucleotides and uses thereof |
| 09/03/2002 | US6444793 Hydrophobically-modified hedgehog protein compositions and methods |
| 09/03/2002 | US6444792 CTLA4-Cγ4 fusion proteins |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444789 CD16-II variants |
| 09/03/2002 | US6444788 Purification |
| 09/03/2002 | US6444644 Peptide having specified amino acid sequence; used for inhibition of thromboplastin |
| 09/03/2002 | US6444642 Administering to mammal effective amount of neuregulin polypeptide with p185.sup.erbb2 protein binding activity to stimulate myogenesis of muscle cells |
| 09/03/2002 | US6444468 Treating a sample comprising different double-stranded template polynucleotides wherein said different template polynucleotides contain areas of identity and areas of heterology under conditions which provide for the cleavage of |
| 09/03/2002 | US6444463 Neurogenic differentiation gene neurod3 and methods for inducing differentiation of cells |
| 09/03/2002 | US6444456 Human G-coupled protein receptor kinases and polynucleotides encoding the same |
| 09/03/2002 | US6444446 Calcium binding proteolipid compositions and methods |
| 09/03/2002 | US6444445 Genetic engineering |
| 09/03/2002 | US6444444 Immunogenic composition, comprising at least one nucleic acid fragment as an active component thereof and vector for transformation of a host comprising the nucleic acid fragment |
| 09/03/2002 | US6444443 Gene |
| 09/03/2002 | US6444442 Method of producing a recombinant non-glycosylated gp90 of equine infectious anemia virus (EIAV), and product thereof |
| 09/03/2002 | US6444440 Vanilloid receptor-2 |
| 09/03/2002 | US6444439 Cloning and characterization of a cdc15-like adaptor protein (CD2BP1) |
| 09/03/2002 | US6444438 Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | US6444430 Ndr2-related proteins |
| 09/03/2002 | US6444425 Compositions may comprise one or more lung tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a lung |
| 09/03/2002 | US6444419 Genes to human cancers and its use in the diagnosis and prognosis of human cancer and screening of drugs for cancer |
| 09/03/2002 | US6444247 Preparation of milk fat globule membranes in tablet or capsule form |
| 09/03/2002 | US6444226 Purification and stabilization of peptide and protein pharmaceutical agents |
| 09/03/2002 | US6444211 Remove pertussis toxin and filamentous haemagglutinin from bordetella pertussis, precipitating pertactin by ammonium sulphate, passing through hydroxyapatite and q-sepharose and ultrafilitrating |
| 09/03/2002 | US6444209 Hybrid botulinal neurotoxins |
| 09/03/2002 | US6444207 Binding with epitope of antigen; anticancer agents |
| 09/03/2002 | US6444202 Genetic engineering; immunsuppressants |
| 09/03/2002 | CA2232985C Methods for treating cancers and restenosis with p21 |
| 09/03/2002 | CA2228195C Transgenic insect virus for use as a biopesticide |
| 09/03/2002 | CA2223566C Method for identifying or isolating a molecule and molecules identified thereby |
| 09/03/2002 | CA2160764C Fish pancreatic disease virus |
| 09/03/2002 | CA2154274C Novel genes, polypeptides, and compositions for cold tolerance and drought resistance in plants |
| 09/03/2002 | CA2079778C Inhibitors of thrombin |
| 09/03/2002 | CA2001815C Products and methods for controlling the suppression of the neoplastic phenotype |
| 09/03/2002 | CA1341387C Human manganese superoxide dismutase (hmn-sod) |
| 09/02/2002 | CA2335411A1 Medical devices for modulation of apoptosis and immune response |
| 08/29/2002 | WO2002066989A2 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms |
| 08/29/2002 | WO2002066682A2 Rat toxicologically relevant genes and uses thereof |
| 08/29/2002 | WO2002066668A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 08/29/2002 | WO2002066660A2 Method for identifying herbicidally active substances |
| 08/29/2002 | WO2002066657A1 Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule |
| 08/29/2002 | WO2002066652A2 Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use |
| 08/29/2002 | WO2002066651A2 Nucleotide sequences of the ribosomal protein s12 gene (rpsl) from corynebacterium glutamicum |
| 08/29/2002 | WO2002066650A2 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 08/29/2002 | WO2002066648A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066645A2 Mutant pro-neurotrophin with improved activity |
| 08/29/2002 | WO2002066644A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 08/29/2002 | WO2002066643A2 Proteins, polynucleotides encoding them and methods of using the same |
| 08/29/2002 | WO2002066642A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/29/2002 | WO2002066641A1 Pg-3 and biallelic markers thereof |
| 08/29/2002 | WO2002066640A2 Zinc finger binding domains for nucleotide sequence ann |
| 08/29/2002 | WO2002066639A1 Brain aneurysm-sensitive gene |
| 08/29/2002 | WO2002066636A2 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | WO2002066634A1 Lectins for analyzing sugar chains and method of using the same |